Future Technology Trends and Upcoming Players in Hemophilia Therapeutics Market

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

U.S. Physical Therapy, Inc.

U.S. Physical Therapy, Inc.

  • $ 55
  • Company report
  • by Wright Investors' Service
  • September 2014
  • 56 pages

A textual analysis of the financial results for U.S. Physical Therapy, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business ...

Industries: Therapy | Countries: United States

Ocera Therapeutics Inc

Ocera Therapeutics Inc

  • $ 55
  • Company report
  • by Wright Investors' Service
  • September 2014
  • 55 pages

A textual analysis of the financial results for Ocera Therapeutics Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description ...

Industries: Therapy | Countries: United States

Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM

Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM

  • $ 4 995
  • Industry report
  • by GBI Research
  • August 2014
  • 105 pages

Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM Summary GBI Research, the leading business intelligence provider, has released its latest research, "Glioblastoma Multiforme Therapeutics in ...

Industries: Therapy | Countries: Australia, India, Japan, China, World, United States, Asia, Oceania

OpportunityAnalyzer: Graft-Versus-Host Disease - Opportunity Analysis and Forecasts to 2018

OpportunityAnalyzer: Graft-Versus-Host Disease - Opportunity Analysis and Forecasts to 2018

  • $ 7 995
  • Industry report
  • by Global Data
  • August 2014
  • 252 pages

OpportunityAnalyzer: Graft-Versus-Host Disease - Opportunity Analysis and Forecasts to 2018 Summary The main drivers of growth in graft versus host disease over the 2013-2018 forecast period include the increasing numbers of allogeneic hematopoietic stem cell transplants and the increasing use of biologic ...

Industries: Therapy | Countries: United States, World

Non-Invasive Monitoring Systems, Inc. (Symbol:NIMU) SWOT Analysis, Strategy, Revenues and Profits

Non-Invasive Monitoring Systems, Inc. (Symbol:NIMU) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • August 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Non-Invasive Monitoring Systems, Inc. SWOT Analysis report provides ...

Industries: Therapy | Countries: United States

PC Group, Inc. (Symbol:PCGR) SWOT Analysis, Strategy, Revenues and Profits

PC Group, Inc. (Symbol:PCGR) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • August 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. PC Group, Inc. SWOT Analysis report provides you a strategic analysis ...

Industries: Therapy | Countries: United States

Cyberonics, Inc. (Symbol:CYBX) SWOT Analysis, Strategy, Revenues and Profits

Cyberonics, Inc. (Symbol:CYBX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • August 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Cyberonics, Inc. SWOT Analysis report provides you a strategic analysis ...

Industries: Therapy | Countries: United States

Big Biotech Deals and Alliances of 2013

Big Biotech Deals and Alliances of 2013

  • $ 1 495
  • Industry report
  • by Currentpartnering
  • August 2014
  • 200 pages

A review of big biotech partnering trends and comprehensive directory of deals and alliances announced during 2013. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and ...

Industries: Therapy | Countries: United States

Dermira Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Dermira Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • July 2014
  • 23 pages

Summary Dermira Inc. (Dermira) is a biotechnology company. The company develops and commercializes therapies in dermatology. It uses innovative science to advance therapeutics in dermatology. Dermira provides DRM01, a topical sebum inhibitor targeting acne and sebaceous gland hyperactivity; and DRM02, ...

Industries: Therapy | Countries: United States

Helix Therapeutics LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Helix Therapeutics LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • July 2014
  • 17 pages

Summary Helix Therapeutics LLC (Helix) is a development stage pharmaceutical company, engaged in research, development, production and commercialization of novel treatments for genetic diseases. Helix is principally focused on developing innovative therapeutic products for hemoglobin, immune and lysosomal ...

Industries: Therapy | Countries: United States

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.